Please assess the completion status of the following clinical trial:

Trial Title: Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Female~* Age 45 or greater~* Diagnosed with operable invasive breast cancer, T1 and T2 (\< 3.5 cm), N0, M0, confirmed by cytological or histological examination~* Suited for breast conserving surgery~* Have had an ipsilateral (same side as current cancer) diagnostic mammogram within 12 months of enrollment~Exclusion Criteria:~* age 44 or less~* Axillary lymph node positive breast cancer~* Invasive lobular cancer~* Tumor size \> 3.5 cm~* Extensive Intraductal Component (EIC= \> 25% of the lumpectomy specimen involved with ductal carcinoma in situ, DCIS) as assessed on surgical pathologic lumpectomy specimen~* Multicentric cancer in the same breast not amenable to excision with a single lumpectomy~* Inability to assess pathologic margin status~* Synchronous bilateral breast cancer at the time of diagnosis.~* Ipsilateral breast had a previous cancer and/or prior in-field radiation.~* Patients known to have BRCA1/2 gene mutations~* Neoadjuvant treatment (hormones or chemotherapy)

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).